Amanote Research
Register
Sign In
Decreased Flares of Rheumatoid Arthritis During the First Year of Etanercept Treatment: Further Evidence of Clinical Effectiveness in the "Real World"
Annals of the Rheumatic Diseases
- United Kingdom
doi 10.1136/ard.61.7.638
Full Text
Open PDF
Abstract
Available in
full text
Categories
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Date
July 1, 2002
Authors
Y Yazici
Publisher
BMJ
Related search
Real-World Effectiveness of Biologic Disease-Modifying Antirheumatic Drugs for the Treatment of Rheumatoid Arthritis After Etanercept Discontinuation in the United Kingdom, France, and Germany
Clinical Therapeutics
Pharmacology
Treatment of Patients With Rheumatoid Arthritis: Real World Population-Based Evidence From France
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pharmacogenetics of Etanercept in Rheumatoid Arthritis
Pharmacogenomics
Molecular Medicine
Genetics
Pharmacology
The Cost-Effectiveness of Alternative Treatment Sequences in Rheumatoid Arthritis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pms54 - Cost-Effectiveness Analysis of Etanercept as First Line of Treatment in Colombian Patients With Psoriatic Arthritis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Co1 Comparative Effectiveness Analysis of TNF Blockers in Rheumatoid Arthritis (Ra) Patients in a Real-World Setting
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
THU0159 Barriers to Rheumatoid Arthritis Treatment Optimisation: Real-World Data From the Arthritispower Registry
Anti-Atherosclerotic Effects of Etanercept in Rheumatoid Arthritis Patients
Japanese Journal of Clinical Immunology
SAT0193 Early Discontinuation of First Line Biological Treatment With Etanercept in Patients With Rheumatoid Arthritis: Results From the Italian Gisea Registry
